VitaPCR™ SARS-CoV-2 Gen 2 Assay

TESTS

BEDIENUNGSANLEITUNG

Klicken Sie hier, um die Bedienungsanleitung in den verschiedenen Sprachen herunterzuladen.

The Pandemic

Coronavirus Disease 2019 (COVID-19), an acute respiratory illness caused by infection with the SARS-CoV-2, was initially reported to WHO in Wuhan, China, on December 31, 2019. The SARS-CoV-2 can be transmitted from person to person through the nose, eyes, or mouth. Furthermore, symptoms of SARS-CoV-2 infection vary. It can be asymptomatic or cause mild illnesses, including a runny nose, sore throat, cough, and fever. However, in severe cases, it can lead to pneumonia, breathing difficulties, or death. To date, millions of people around the world have died from COVID-19.

The Need

As the world continues to combat COVID-19, SARS-CoV-2 testing keeps playing a crucial role in stopping the spread of the virus and future variants. Particularly, a rapid and accurate diagnostic test for SARS-CoV-2 detection at the Point-of-Care becomes essential and generally adopted to help healthcare professionals to make decisions on the spot.

The Solution

VitaPCR™ SARS-CoV-2 Gen 2 Assay based on the proprietary RT-PCR technology provides significantly faster testing results than any other laboratory-based methods with higher accuracy than conventional rapid testing. With less than a minute of hands-on time, the test allows the detection of SARS-CoV-2 in 20 minutes from sample to results. On top of that, the comprehensive results information, including Ct values and fluorescence curves, can help healthcare providers make precise decisions and offer proper treatments in a timely manner.

Benutzerfreundlichkeit

Leistung

Diagnostisches Verfahren in 3 Schritten

Intuitive Ergebnisinterpretation